Page 5 of 33 · 771 questions tagged coa.
Details up front: a GLP-1 receptor agonist · Janoshik. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
Setup, so nobody has to ask: cagrilintide · sixteen weeks · room temperature. I would rather over-plan the first cycle and simplify later. I am prepared to do the…
Setup, so nobody has to ask: batch certificate · WXT. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
Stated plainly: 99.4% · Medutest · 96.8%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have photographed the…
The specifics, since they change the answer: MKM · Hunan Aslsen Technology. I am trying to choose between two options that are usually discussed as though only one…
The specifics, since they change the answer: 97.6% · PeptideMeter · 98.8%. An unexpected observation, and I would like a differential rather than reassurance. The…
Details up front: 96.8% · a C8 column · liraglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
The particulars: liraglutide · ten weeks · minus 80 °C. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…
The case in front of me: GL Biochem · Hunan Aslsen Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I can predict the outcome but I cannot explain it, which means I will get…
This is my second independent submission on material from the same supplier. I can find plenty of assertions about this and almost no reasoning, which is usually a…
The case in front of me: 98.4% · VendorInvestigate · 98.8%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without…
The specifics, since they change the answer: SWB · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a…
I am comparing three suppliers on documentation rather than on price. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
Concretely: 96.8% · a C4 column · dulaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The specifics, since they change the answer: purity figure · JEEP. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but…
Concretely: FGP · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
Details up front: list of related substances · QYB. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I have: mazdutide · six weeks · 2–8 °C. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I would like to know the limits of what can be inferred from this. What…
I have been through one internal appeal already and would like to do the next one properly. I have the document in front of me and I can read the numbers. What I…
Conditions: 98.4% · VendorInvestigate · 97.6%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
The lot number on the vial matches the certificate, which at least rules out the easy problem. This is a procedural question rather than a theoretical one, and I…
This is my second independent submission on material from the same supplier. I can predict the outcome but I cannot explain it, which means I will get the next case…